FOXP3 and bladder transitional cell carcinoma: Differential expressions of FOXP3 showed no significant impact on BLCA (Figure 8F), PRAD (Figure 8G), and COAD (Figure 8H), while high expression of FOXP3 was associated with a higher percentage of survival in HNSC (Figure 8I).